People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and Europe Completed ZYNQUISTA FDA Advisory Committee Meeting; PDUFA Goal Date December 20, 20 ...

FRIDAY, Nov. 8, 2024 (HealthDay News) -- Women have a higher risk of heart failure and stroke than men while undergoing ...

The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

Drawing inferences from observational data with possible confounding Heart failure is increasing in prevalence and is a major cause of morbidity and mortality worldwide,1 with prevalence ranging from ...

For the study, investigators analyzed medical records of patients who were treated with anti-cancer medications including cytotoxic, targeted immunotherapies over a 1-year period.

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...

On Halloween, Lexicon was haunted again as an FDA advisory committee voted 11-3 to reject Zynquista as an accompanying ...

Lexicon Pharmaceuticals received a negative vote from a Food and Drug Administration advisory committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with Type 1 ...

Lexicon Pharmaceuticals shares have been halted all day as a Food and Drug Administration advisory committee was scheduled to vote on Zynquista as an adjunct to insulin therapy for glycemic control in ...

And concerns remain surrounding the risks for diabetic ketoacidosis (DKA) and hypoglycemia with SGLT2 ... to reduce the risk ...

Filipino celebrity Heart Evangelista, a renowned resident of fashion weeks around the globe, was spotted in Dubai on Friday night. The socialite, who is also a senator’s wife, shared a candid ...